Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pulse Biosciences CS (PLSE)

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 290,752
  • Shares Outstanding, K 20,768
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,550 K
  • 60-Month Beta 1.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.61
  • Number of Estimates 1
  • High Estimate -0.61
  • Low Estimate -0.61
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +4.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.48 +8.09%
on 10/16/19
17.45 -16.50%
on 09/24/19
-1.69 (-10.39%)
since 09/17/19
3-Month
10.60 +37.45%
on 08/09/19
17.45 -16.50%
on 09/24/19
+1.97 (+15.63%)
since 07/17/19
52-Week
8.60 +69.42%
on 10/23/18
19.77 -26.30%
on 03/21/19
+3.76 (+34.78%)
since 10/17/18

Most Recent Stories

More News
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, announced today that the Compensation...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation(TM) Technology at Key Medical Aesthetic Meetings

-- NPS Technology Headlines "New and Emerging Treatments" Session at Harvard Medical School's Annual Laser & Aesthetic Skin Therapy Conference

PLSE : 14.57 (+4.07%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, announced today that the Compensation...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, announced today that the Compensation...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, announced today that the Compensation...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Quarterly Investor Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, today reported recent corporate developments and financial...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Announces Podium Presentation of Nano-Pulse Stimulation(TM) Technology at Major Aesthetic Procedures Conference

Pulse Biosciences, Inc. (NASDAQ:PLSE), a bioelectric medicine technology company bringing to market its proprietary CellFX(TM) System, today announced its patented Nano-Pulse Stimulation(TM) (NPS(TM))...

PLSE : 14.57 (+4.07%)
Pulse Biosciences to Report Second Quarter 2019 Operational Highlights and Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System announced today that the Company...

PLSE : 14.57 (+4.07%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company"), a novel bioelectric medicine company bringing to market its proprietary CellFX(TM) System, announced today that...

PLSE : 14.57 (+4.07%)
Pulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial Results

Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX(TM) System today announced that the Company will report first quarter 2019...

PLSE : 14.57 (+4.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade PLSE with:

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Key Turning Points

2nd Resistance Point 15.36
1st Resistance Point 14.96
Last Price 14.57
1st Support Level 14.11
2nd Support Level 13.65

See More

52-Week High 19.77
Fibonacci 61.8% 15.50
Last Price 14.57
Fibonacci 50% 14.19
Fibonacci 38.2% 12.87
52-Week Low 8.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar